NEW YORK, Sept 22 (Reuters) - Amgen Inc (AMGN.O) is aggressively eyeing global expansion and looking at acquisition opportunities and drug licensing deals that can help the world’s largest biotechnology company to achieve that goal.
NEW YORK, Sept 22 (Reuters) - Amgen Inc (AMGN.O) is aggressively eyeing global expansion and looking at acquisition opportunities and drug licensing deals that can help the world’s largest biotechnology company to achieve that goal.
